Development of novel brown adipocyte recruiters for the treatment of obesity
Ended Project Grant Awarded Last action
- Award ID
- R43DK125193
- Recipient
-
Energesis Pharmaceuticals Inc. UEI JA9AEU5KN7R1
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $295,420
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $295,420 |
Quick answers
Who received award R43DK125193?
R43DK125193 was awarded to Energesis Pharmaceuticals Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on July 1, 2020.
How much is award R43DK125193 worth?
$295,420 has been obligated on R43DK125193.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award